Table 3.
Baseline and 6 months 3D echocardiographic data on SAVR vs TAVI patients
| SAVR (n = 45) | TAVI (n = 42) | SAVR vs TAVIp-value* | |||
|---|---|---|---|---|---|
| mean ± SD | Me (P25-P75) | mean ± SD | Me (P25-P75) | ||
| LVEDVi (ml/ m 2 ) | |||||
| Baseline | 61.77 ± 21.81 | 59 (43.49 - 75.58) | 46.29 ± 13.47 | 46.59 (34.44 - 55.74) | 0.007 |
| 6 months | 51.28 ± 16.63 | 47.64 (38.69 - 59.1) | 42.07 ± 12.87 | 38.89 (33.58 - 48.67) | 0.030 |
| p-value** | 0.001 | 0.173 | |||
| LVESVi (ml/ m 2 ) | |||||
| Baseline | 27.32 ± 14.68 | 21.7 (16.56 - 34.86) | 20.91 ± 9.81 | 18.54 (13.98 - 28.44) | 0.115 |
| 6 months | 21.17 ± 11.46 | 19.54 (13.55 - 24.99) | 16.29 ± 7.99 | 13.56 (10.68 - 23.01) | 0.074 |
| p-value** | 0.002 | 0.004 | |||
| EF (%) | |||||
| Baseline | 57.63 ± 9.38 | 60.1 (54.8 - 63.5) | 55.73 ± 10.15 | 55.45 (49.45 - 59.83) | 0.079 |
| 6 months | 61.28 ± 8.98 | 61.7 (58.55 - 66.95) | 61.27 ± 11.35 | 61 (53.5 - 70.2) | 0.841 |
| p-value** | 0.037 | 0.005 | |||
| LVMI ( g/ m 2 ) | |||||
| Baseline | 135.3 ± 37.5 | 120.1 (108.4 - 160.2) | 137.46 ± 47.76 | 123.13 (97.5 - 173.89) | 0.877 |
| 6 months | 119.5 ± 36.8 | 110.7 (96.5 - 128.0) | 124.44 ± 44.55 | 112.53 (98.75 - 155) | 0.588 |
| p-value** | 0.002 | 0.537 | |||
| LVMI/ LVDVI | |||||
| Baseline | 2.49 ± 0.81 | 2.35 (1.84 - 2.96) | 3.48 ± 1.7 | 3 (2.05 - 4.4) | 0.038 |
| 6 months | 2.46 ± 0.68 | 2.56 (1.9 - 2.92) | 3.01 ± 1.53 | 2.82 (1.81 - 3.65) | 0.334 |
| p-value** | 0.557 | 0.424 | |||
| LAVI (ml/ m 2 ) | |||||
| Baseline | 39.94 ± 14.27 | 37.27 (31.15 - 47.99) | 48.42 ± 14.81 | 47.5 (35.36 - 57.14) | 0.008 |
| 6 months | 38.16 ± 11.9 | 36.17 (30.19 - 45.24) | 40.99 ± 12.7 | 42.63 (29.44 - 50) | 0.425 |
| p-value** | 0.465 | 0.006 | |||
LVDVI = left ventricular end-diastolic volume index; LVSVI = left ventricular end-systolic volume index; EF = ejection fraction; LVMI = left ventricular mass index; LAVI = left atrial volume index; *Mann–Whitney test; **Wilcoxon test.